GSK plc GSK
NYSE GSK
$46.50 -0.02 (-0.04%)
At close: Oct 9, 2026 · 4:00 PM EDT

Gsk (GSK) Current Deferred Revenue (2016 - 2018)

Updated

Gsk (GSK) posted Current Deferred Revenue of $277.94 million for the quarter ended Dec 31, 2018, down 12.8% from $318.64 million a year earlier.

Analysis

Gsk (GSK) Current Deferred Revenue (2016 - 2018) Analysis & Trends

As of Dec 31, 2018, Gsk's Current Deferred Revenue came in at $288.48 million, down 6.7% from the prior year.

  • In prior years, Gsk's Current Deferred Revenue was $309.18 million in the year ended Dec 31, 2017 (+44.2%) and $214.35 million in the year ended Dec 31, 2016.
  • The figure for the quarter ended Dec 31, 2018 stands as the lowest quarterly Current Deferred Revenue since the quarter ended Dec 31, 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn
10 Gsk 100.33 Bn 81.91 Bn 8.24 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 277.94 Mn
Dec 31, 2017 318.64 Mn
Dec 31, 2016 196.43 Mn
API Access

Gsk Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=GSK&period=max&api_key=YOUR_API_KEY